The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism

Annals of Surgery

Volumn 253, Issue 1, 2011, Pages 131-137

  Roman, Sanziana A ^a   Sosa, Julie Ann ^a   Pietrzak, Robert H ^a   Snyder, Peter J ^c   Thomas, Daniel C ^a   Udelsman, Robert ^a   Mayes, Linda ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE; THYROTROPIN;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BRIEF SYMPTOM INVENTORY; CALCIUM BLOOD LEVEL; COGNITION; COMORBIDITY; DEPRESSION; FEMALE; FOLLOW UP; GROTON MAZE LEARNING TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; NEUROPSYCHOLOGICAL TEST; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REY AUDITORY VERBAL LEARNING TEST; SPATIAL MEMORY; STATE TRAIT ANXIETY INVENTORY; THYROTROPIN BLOOD LEVEL; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

ADULT; ANXIETY; CALCIUM; COGNITION; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MEMORY; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; TREATMENT OUTCOME;

EID: 78751635194     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181f66720     Document Type: Article

References (41)

1. Wermers RA, Khosla S, Atkinson EJ, et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med. 1998;104(2):115-122
2. Potts JTJr, Fradkin JE, Aurbach GD,etal, eds. Proceedings ofthe NIH Consensus Development Conference on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism, Bethesda, Maryland, October 29-31, 1990. J Bone Miner Res. 1991;6(suppl 2):S1-S166.
3. Bilezikian JP, Potts Jr JT, Fuleihan GE, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87(12):5353-5361
4. [reprinted from J Bone Miner Res 17(suppl 2):N2-N11].
5. Udelsman R, Pasieka JL, Sturgeon C, et al. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):366-372.
6. Pasieka JL, Parsons LL, Demeure MJ et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg. 2002;26;942-949.
7. Talpos GB, Bobe HG, Kleerekoper M, et al. Randomized trial of parathyroidec-tomy in mild asymptomatic primary hyperparathyroidism: patient description and effects of the SF-36 health survey. Surgery. 2000;128:1013-1021.
8. Rao DS, Phillips ER, Divine GW, et al. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2004;89(11):5414-5422.
9. Roman SA, Sosa JA, Mayes L, et al. Parathyroidectomy improves neu-rocognitive deficits in patients with primary hyperparathyroidism. Surgery. 2005;138:1121-1129.
10. Walker MD, McMahon DJ, Inabnet WB, et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab. 2009:94(6):1951-1958.
11. De Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56(3):221-229.
12. Waldman E, Potter JF. A prospective evaluation of cumulative illness rating scale. Aging. 1992;4(2):171-178.
13. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
14. Spielberger CD. Manual for the State-Trait Anxiety Inventory Form Y, Self-Evaluation Questionnaire. Palo Alto, CA: Consulting Psychologists Press; 1983.
15. Derogatis LR. Brief Symptom Inventory (BSI)-18. Administration, Scoring and Procedures Manual. Minneapolis, MN: NCS Pearson Inc; 2001.
16. Numann PJ, Torppa AJ, Blumetti AE. Neuropsychologic deficits associated with primary hyperparathyroidism. Surgery. 1984;96(6):1119-1123.
17. Prager G, Kalaschek A, Kaczirek K, et al. Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery. 2002;132(6):930-935.
18. Chiang CY, Andrewes DG, Anderson D, et al. A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hy-poparathyroid patients. Clin Endocrinol. 2005;62(1):99-104.
19. Boulanger M, Snyder PJ, Cohen H. Ralentissement cognitif dans le vieil-lissement: fonctions exécutives et apprentissage procédural lors d'une tâche informatisée de labyrinthe. Ann Méd-Psycholog Revue Psychiatrique. 2006;164:463-469.
20. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. 3rd ed. New York, NY: Oxford University Press; 2006.
21. Pietrzak RH, Maruff P, Mayes LC, et al. An examination of the construct validity and factor structure of the Groton Maze Learning Test, a new measure of spatial working memory, learning efficiency, and error monitoring. Arch Clin Neuropsychol. 2008;23(4):433-445.
22. Pietrzak RH, Cohen H, Snyder PJ., et al. Spatial learning efficiency and error monitoring in normal aging: an investigation using a novel hidden maze learning test. Arch Clin Neuropsychol. 2007;22(2):235-245.
23. Bland JM, Altman DG. Measurement error. BMJ. 1996;313:744.
24. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hills-dale, NJ: Erlbaum; 1988.
25. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model. 1999;6:1-55.
26. Kline RB. Principles and Practice of Structural Equation Modeling. 2nd ed. New York, NY: Guilford Press; 2005.
27. Kistler H. Primary hyperparathyroidism: an analysis of 152 patients with special references to acute life threatening complications (acute hyperparathy-roidism). Schweiz Med Wochenschr. 1976:106(suppl 3):1-61.
28. Wang CA, Guyton SW. Hyperparathyroid crisis: clinical and pathologic study of 14 patients. Ann Surg. 1979;190(6):782-790.
29. Schram MR, Trompet S, Kamper AM, et al. Serum calcium and cognitive function in old age. J Am Geriatr Soc. 2007;55(11):1786-1792.
30. Weber T, Keller M, Hense I, et al. Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg. 2007;31(6):1202-1209.
31. Jorde R, Waterloo K, Saleh F, et al. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Trǿmso study. J Neurol. 2006;253(4):464-470.
32. Usdin TB, Wang T, Hoare SR, et al. New members of the parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues. Front Neuroendocrinol. 2000;21(4):349-383.
33. Cermik TF, Kaya M, Ugur-Altun B, et al. Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism. Neuroradiology. 2007;49(4):379-385.
34. Mjaland O, Normann E, Halvorsen E, et al. Regional cerebral blood flow in patients with primary hyperparathyroidism before and after successful parathy-roidectomy. Br J Surg. 2003;90:732-737.
35. Yarnell PR, Caplan LR. Basilar artery narrowing and hyperparathyroidism: illustrative case. Stroke. 1986;17:1022-1024.
36. Garcia dela Torre N, Wass JAH, Turner HE. Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer. 2003;10:309-322.
37. Walker MD, Silverberg SJ Cardiovascular aspects of primary hyperparathy-roidism. J Endocrinol Invest. 2008;31(10):925-931.
38. Benge JF, Perrier ND, Massman PJ, et al. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy J Int Neuropsychol Soc. 2009;1-10.
39. Lemay S, Bédard MA, Rouleau I, et al. Practice effect and test-retest reliability of attentional and executive tests in middle-aged to elderly subjects. Clin Neuropsychol. 2004;18:284-302.
40. Pietrzak RH, Snyder PJ, Jackson CE, et al. Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals. Hum Psychopharmacol. 2009;24:113-121.
41. Thompson AJ, Lummis SCR. Calcium modulation of 5-HT3 receptor binding and function. Neuropharmacology. 2009;56:285-291.